Dr. Indu Srinivasan, MD

Dr. Srinivasan practices at Valleywise Health Medical Center in Phoenix, Arizona, part of Valleywise Health.

Dr. Srinivasan's NPI, 1972815967, was assigned on July 8, 2010. Dr. Srinivasan holds Mississippi license 22686.

Dr. Srinivasan's primary practice is Valleywise Health Medical Center, at 2601 East Roosevelt Street, Phoenix, AZ 85008 in Maricopa County. The practice phone is (602) 344-5011.

Dr. Srinivasan's primary practice is Valleywise Health Medical Center in Phoenix, Arizona, part of Valleywise Health. The medical group on file is District Medical Group. Dmand AI also links Dr. Srinivasan to 1 more dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Srinivasan practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Srinivasan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Srinivasan's licenses on file in 2 states: Mississippi and Massachusetts.

CMS data shows 32 Medicare services from Dr. Srinivasan across 2 procedure codes in 2024, for 69 Medicare patients. Medicare paid $2,777 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 69 Medicare patients who saw Dr. Srinivasan in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 58% have high cholesterol. 70% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Srinivasan's median patient age at 55, with 56% women.

In 2024, Dr. Srinivasan wrote 26 Medicare Part D claims for 20 patients. 88% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $389 in total drug cost. In 2022, CMS named 14 claims across 1 drug.

Dr. Srinivasan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Srinivasan, more than 51% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Srinivasan, published from 2011 to 2025. 2012 was the busiest year, with 3. The most frequent topics are Stents, Cholangiopancreatography, Endoscopic Retrograde and Endosonography. Dr. Srinivasan has published most often in Cureus. Dr. Srinivasan's most frequent co-authors are Keng-Yu Chuang, MD, Dimas Kosa and Mustafa Alani, MD.

CMS Open Payments shows 134 general payments to Dr. Srinivasan from 25 drug and device companies from 2016 to 2025. Grants make up the largest share, 77% of the total. Boston Scientific Corporation paid the most, $13,105.